BiotechTube
Home/Genfit/Dean Hum
DH

Dean Hum

Chief Scientific Officer

Genfit

Therapeutic Areas

Metabolic DiseasesLiver DiseasesGastroenterology

Genfit Pipeline

DrugIndicationPhase
Elafibranor (GFT505)Primary Biliary Cholangitis (PBC)Phase 3
NIS4® TechnologyDiagnosis of at-risk NASH (F≥2)Commercial

Leadership Team at Genfit

PP
Pascal Prigent
Chief Executive Officer
JM
Jean-François Mouney
Co-Founder & Chairman of the Board
SM
Sophie Mégnien
Chief Medical Officer
ND
Nicolas Decourt
Chief Business Officer
LD
Laurent de Narbonne
Chief Commercial Officer
YB
Yannick Borsu
Chief Financial Officer
KB
Katherine B. McCarthy
Independent Director, Board Member
SM
Susan M. Byrne
Independent Director, Board Member
BL
Bénédicte Lallemand
Independent Director, Board Member
LL
Lucie Larguier
SVP, General Counsel & Corporate Secretary
View full Genfit profile